Company profile: Medfusion Services
1.1 - Company Overview
Company description
- Provider of integrated clinical laboratory and clinical trial services, offering diagnostic testing (solid tumor, hematopathology, women's health, urology, general health), molecular diagnostics and test development, pathology services, and clinical trial support including specimen collection, processing, testing, and guidance for specimen packaging and shipping.
Products and services
- Molecular Diagnostics: Specializes in developing and validating molecular tests for various medical conditions in a validation-driven model that integrates services for the healthcare providers they support
- Clinical Laboratory Services: Delivers diagnostic testing across solid tumor, hematopathology, women’s health, urology, and general health using a clinical-grade approach aligned with integrated services for supported healthcare providers
- Clinical Trials Support: Delivers clinical trials support, including specimen collection, processing, and testing, for biotech and pharmaceutical companies in a biotech/pharma-focused model
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medfusion Services
Cellestia
HQ: Switzerland
Website
- Description: Provider of clinical-stage R&D therapies to control and modulate pathogenic gene expression via selective inhibition of transcription factors in the cell nucleus. Lead candidate CB-103 targets the CSL-NOTCH complex and is in Phase 2 for various cancers and GvHD, showing efficacy in multi-drug resistant cancers and autoimmune diseases. Pipeline includes preclinical assets for psoriasis, Sjogren’s, SLE, IBD and giant cell arteritis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellestia company profile →
Theraclone Sciences
HQ: United States
Website
- Description: Provider of novel therapeutic antibodies and an antibody discovery platform for infectious diseases and inflammation. Offers a comprehensive screening technology to identify rare human monoclonal antibodies, HIV broadly neutralizing fully human antibodies licensed to Gilead for HIV-cure regimens, and platform technology licensed to OncoResponse for oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Theraclone Sciences company profile →
NovaScan
HQ: United States
Website
- Description: Provider of cancer detection and surgical decision-support technologies based on Cole frequency measurements, including MarginScan for tissue-sparing skin cancer excisions with margin confirmation without histology; nsCanary for real-time biopsy assessment (pancreatic, biliary, lung); Predictive Technology to assess presence, aggressiveness, and metastasis likelihood; and an Electrical Mammogram detecting breast cancer without radiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NovaScan company profile →
Immago
HQ: United Kingdom
Website
- Description: Provider of antibody-modulating enzyme approaches to enhance antibody-based cancer therapies, applying 'receptor refocusing' to modulate the endogenous antibody repertoire and enhance immune-mediated killing of cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immago company profile →
Waverley Pharma
HQ: Canada
Website
- Description: Provider of specialty pharmaceutical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Waverley Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medfusion Services
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medfusion Services
2.2 - Growth funds investing in similar companies to Medfusion Services
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medfusion Services
4.2 - Public trading comparable groups for Medfusion Services
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →